Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/1998
12/16/1998EP0883628A1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof
12/16/1998EP0883596A1 Fluorinated propranolol and related methods
12/16/1998EP0669934B1 Process for manufacturing crystals of growth hormone and crystals thereby obtained
12/16/1998CN1202164A Diarylalkenylamine derivatives
12/15/1998US5849708 Promotion of eating behavior
12/15/1998US5849535 Human growth hormone variants
12/10/1998WO1998055505A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/10/1998WO1998055499A1 11β-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055479A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055470A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055136A1 Fsh-releasing peptides
12/10/1998WO1998055123A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055116A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998030590A3 Analogs of parathyroid hormone
12/10/1998DE19723722A1 Nichtsteroidale Gestagene Non-steroidal progestins
12/10/1998CA2293664A1 Fsh-releasing peptides
12/10/1998CA2292881A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292880A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292605A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292525A1 11.beta.-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments
12/10/1998CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291647A1 Antagonists of gonadotropin releasing hormone
12/09/1998EP0882736A1 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
12/09/1998EP0882051A1 Thiophenopyrimidines
12/09/1998EP0882040A1 Antagonists of gonadotropin releasing hormone
12/09/1998EP0881908A1 Use of fibroblast growth factors to stimulate bone growth
12/09/1998EP0881901A1 New associations of active principles containing clopidogrel and an antithrombotic agent
12/09/1998EP0881891A1 Male contraceptive implant
12/09/1998CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate
12/09/1998CN1201454A Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
12/09/1998CN1201392A Pentacyclic compounds, intermediates, preparation process, compositions and methods thereof
12/09/1998CN1201389A Method and pharmaceutical composition for regulating lipid concentration
12/09/1998CN1041096C Fluorinated 17 beta-substituted 4-aza-5 alpha-androstane-3-one derivatives
12/09/1998CN1041095C Steroid compounds for treatment of prostatic hypertrophy, and its medicinal composition thereof
12/08/1998US5846711 Nuclear hormone receptor-interacting polypeptides and related molecules and methods
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054222A1 Cyclic crf agonists
12/03/1998WO1998054159A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/03/1998WO1998053844A1 Pharmaceutical compostions of peptides having low solubility in physiological medium
12/03/1998DE19724187A1 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln 11beta-aryl-substituted 14,17-ethanoestratrienes, processes for preparing these compounds, and their use for the preparation of medicaments
12/03/1998CA2291765A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998EP0880969A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/02/1998EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998EP0880496A1 Biphenyl compounds and use thereof as oestrogenic agents
12/02/1998EP0880366A1 SKIN-ADHERING PHARMACEUTICAL PREPARATION, IN PARTICULAR TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL TO THE HUMAN ORGANISM
12/02/1998CN1200674A Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
12/01/1998US5843940 Benzothiophene compounds, compositions, and method
12/01/1998US5843932 Therapeutic methods and delivery systems utilizing sex steroid precursors
12/01/1998US5843931 6,7-modified 11β-aryl-4-oestrenes
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843901 LHRH antagonist peptides
11/1998
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879603A1 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof
11/25/1998EP0879282A1 Immunotherapy using cytotoxic t lymphocytes (ctl)
11/25/1998EP0879227A1 Tyrosin-derivate as alpha-v-integrin inhibitors
11/25/1998EP0879050A1 Captopril tablets
11/25/1998EP0689458B1 Active-substance patch for releasing estradiol to the skin
11/25/1998CN1200126A Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
11/25/1998CN1200035A Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
11/24/1998US5840853 Parathyroid hormone receptor and DNA encoding same
11/24/1998US5840735 Estrogen
11/19/1998WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998WO1998051687A1 Piperidino derivatives which promote growth hormone release
11/19/1998WO1998051678A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
11/19/1998WO1998051664A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998051324A1 Peptide parathyroid hormone analogs
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2290443A1 Peptide parathyroid hormone analogs
11/19/1998CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998CA2288710A1 3-epi vitamin d2 compounds and uses thereof
11/18/1998EP0877807A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
11/18/1998EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor
11/18/1998EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998EP0877607A1 Biphenyl compounds and use thereof as oestrogenic agents
11/18/1998EP0673254A4 6-position modified decapeptide lhrh antagonists.
11/18/1998CN1199340A Analogs of parathyroid hormone
11/18/1998CN1199337A Method of inhibiting plasminogen activator inhibitor 1
11/17/1998US5837700 Therapeutic methods and delivery systems utilizing sex steroid precursors
11/17/1998US5837244 Treating a cell proliferative disorder
11/12/1998CA2289001A1 Novel heterocyclic compounds
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998EP0876337A2 New lh-rh antagonists with improved effectiveness
11/11/1998EP0876131A1 Drug delivery compositions for improved stability of steroids
11/11/1998EP0800386B1 Transdermal system for the simultaneous delivery of a number of active principles
11/11/1998CN1198735A Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
11/11/1998CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834501 Heterocyclic compounds having anti-diabetic activity and their use
11/10/1998US5834463 Condensed heterocyclic compounds, their production and use
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998048825A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998WO1998048806A1 Indene compounds having activity as serms
11/05/1998WO1998034583A3 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
11/05/1998CA2287910A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998CA2287244A1 Indene compounds having activity as serms
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 290